Manitty Selected for Phase 2 of NATO DIANA Programme
A Milestone for Innovation and Dual-Use Impact
Manitty is proud to announce that we have been selected as one of just 15 companies advancing to Phase 2 of NATO’s Defence Innovation Accelerator for the North Atlantic (DIANA) Programme. This recognition marks a defining moment in our journey as innovators in health technology, and we are honoured to represent France in this next stage of NATO’s prestigious accelerator.
From over 2,600 proposals submitted across NATO member and partner nations, only 73 companies advanced to Phase 1. Following months of diligence, evaluations, and technical reviews, that number has now been narrowed to 15 Phase 2 innovators. Manitty’s selection is a testament to both our team’s dedication and the strategic potential of our flagship innovation, DeepMo Remote Health Monitoring technology.
DeepMo: From Hospitals to the Battlefield
DeepMo was originally conceived as a remote patient monitoring solution for hospitals and home care. Our vision was to give clinicians and caregivers real-time insights into patient health, enabling early detection of complications and supporting personalized care plans.
As our technology evolved, it became clear that DeepMo’s features — wearable sensors, AI-driven multimodal data analysis, and predictive anomaly detection — could serve not only hospitals and patients, but also soldiers, medics, and commanders in the field.
By adapting DeepMo for defence use, we created a soldier-specific system that:
- Operates reliably in combat and other high-stress environments.
- Continuously tracks vital signs and physiological indicators.
- Detects early warning signals of health deterioration before they escalate.
- Provides predictive insights and decision support to medics and mission leaders.
This dual-use versatility — bridging civilian healthcare and military resilience — is precisely what NATO DIANA seeks to accelerate.
Advanced Features That Make a Difference
DeepMo is not just another wearable. It is a comprehensive health intelligence platform designed to perform in the most demanding environments. Its advanced capabilities include:
- Lightweight, wearable form factor: Practical for both patients at home and soldiers in the field.
- Multimodal data collection: Captures heart rate, respiration, movement, brain activity, and more.
- AI-powered predictive analytics: Detects anomalies before they become critical, enabling early interventions.
- Real-time decision support: Translates raw data into actionable insights for clinicians, medics, and commanders.
- Interoperability: Integrates seamlessly with existing healthcare systems and, in the defence context, with secure military communication networks.
- Resilience: Engineered for reliability in harsh conditions — whether a hospital ward, disaster zone, or battlefield.
By combining these features, DeepMo delivers what we believe is the future of healthcare: continuous, intelligent, and predictive monitoring that saves lives.
The Strategic Fit with DIANA
The Defence Innovation Accelerator for the North Atlantic (DIANA) is NATO’s dedicated innovation engine. Its mission is to find, accelerate, and promote the adoption of dual-use technologies that can strengthen the Alliance in the face of evolving threats.
Phase 2 of the programme is a highly selective stage where innovators like Manitty receive:
- €300,000 in additional funding to accelerate development.
- Continued access to NATO test centres for validation.
- Tailored mentorship and support from DIANA advisors and experts.
- Opportunities to connect directly with end users and NATO stakeholders.
For Manitty, Phase 2 is both a recognition of our progress and a catalyst for our next leap forward.
Dual-Use Value: Benefits for Defence and Society
One of DeepMo’s greatest strengths is its dual-use potential. By serving both civilian and defence domains, it creates value across multiple dimensions of society:
For patients and healthcare systems:
- Continuous monitoring after surgery or in chronic disease management.
- Early intervention that prevents hospital readmissions and reduces healthcare costs.
- Greater accessibility for patients with limited mobility or those in rural areas.
For soldiers and defence operations:
- Improved operational readiness by monitoring health under stress.
- Enhanced safety through early detection of heat stress, fatigue, or injury.
- Better post-mission recovery with continuous health insights.
- Data-driven support for medics in mass-casualty or battlefield triage scenarios.
For society at large:
- Applications in disaster relief, humanitarian missions, and emergency response.
- Contribution to public health resilience through scalable, predictive monitoring.
- A model of how defence innovation can generate civilian benefits, and vice versa.
Voices of Leadership
Philippe Blasquez, CEO of Manitty, commented:
“Being selected for Phase 2 of DIANA is a tremendous recognition of our team’s work. With DIANA’s support, we can accelerate DeepMo’s impact, ensuring soldiers and healthcare professionals alike benefit from real-time, AI-powered health insights. This is not just about technology — it’s about saving lives and strengthening resilience.”
James Appathurai, Managing Director of NATO DIANA, added:
“DIANA is NATO’s innovation engine. We are finding the most innovative technologies from the market; we are helping these talented innovators fine-tune their technologies and grow their businesses; and we are connecting the companies to end users so that NATO defence ministries can adopt new technologies at the speed of relevance, including through DIANA’s Rapid Adoption Service. Phase 2 is a pivotal stage in our Accelerator Programme, and I congratulate these companies for making and taking this next step.”
Looking Ahead
As we enter Phase 2, Manitty is focused on:
- Scaling the development of DeepMo for greater robustness in extreme environments.
- Expanding partnerships across NATO’s innovation ecosystem.
- Validating DeepMo in real-world operational scenarios.
- Accelerating adoption in both defence and healthcare systems.
Our commitment is clear: to push the boundaries of innovation, to protect lives, and to contribute to a more secure, future-ready Alliance. We are proud to represent France as part of this journey and excited to see where Phase 2 with NATO DIANA will take us.